It turns out that about half of all people carry the slow-metabolizer version of the CYP1A2 gene. This means millions of ...
After a person quits smoking, an important consideration is how quickly the induction of CYP1A2 dissipates. The primary pharmacokinetic interactions with smoking occur with drugs that are CYP1A2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback